U.S. flag

An official website of the United States government

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 4

1.
Fig. 1

Fig. 1. From: Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature.

Diagram outlining the flow of newly diagnosed AML patients treated with AcDVP16.

Kelly J. Norsworthy, et al. Leuk Res. ;61:25-32.

CitationFull text

2.
Fig. 2

Fig. 2. From: Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature.

Kaplan-Meier curves for overall survival (a) and disease-free survival (b) in newly diagnosed AML patients treated with TST induction. Survival data is presented in .

Kelly J. Norsworthy, et al. Leuk Res. ;61:25-32.

CitationFull text

3.
Fig. 4

Fig. 4. From: Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature.

Survival by HiDAC or AcDAc consolidation alone, without eventual BMT. The population average treatment effect (HR) was estimated by Cox proportional hazard model with propensity score weighting method.

Kelly J. Norsworthy, et al. Leuk Res. ;61:25-32.

CitationFull text

4.
Fig. 3

Fig. 3. From: Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature.

Kaplan-Meier curves for overall survival in newly diagnosed AML patients by age (a), cytogenetics (b), and de novo versus secondary AML (c). P-values correspond to log-rank test. Survival data is presented in .

Kelly J. Norsworthy, et al. Leuk Res. ;61:25-32.

CitationFull text

Supplemental Content

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center